We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
USA - July 20 2012
The United States Court of Appeals for the Federal Circuit ruled, en banc, to reverse its own precedent and close the remedy gap for patentees seeking to pursue infringement claims against the United States where the infringing product has been made outside the U.S., either in whole or in part.
